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Abstract
Aims/hypothesis In mammals, the evolutionary conserved
family of Mg2+-dependent phosphatidate phosphatases
(PAP1), involved in phospholipid and triacylglycerol
synthesis, consists of lipin-1, lipin-2 and lipin-3. While
mutations in the murine Lpin1 gene cause lipodystrophy
and its knockdown in mouse 3T3-L1 cells impairs
adipogenesis, deleterious mutations of human LPIN1 do
not affect adipose tissue distribution. However, reduced
LPIN1 and PAP1 activi ty has been descr ibed in
participants with type 2 diabetes. We aimed to characterise
the roles of all lipin family members in human adipose
tissue and adipogenesis.
Methods The expression of the lipin family was analysed in
adipose tissue in a cross-sectional study. Moreover, the effects
of lipin small interfering RNA (siRNA)-mediated depletion
on in vitro human adipogenesis were assessed.
Results Adipose tissue gene expression of the lipin family is
altered in type 2 diabetes. Depletion of every lipin family
member in a human Simpson–Golabi–Behmel syndrome
(SGBS) pre-adipocyte cell line, alters expression levels of
adipogenic transcription factors and lipid biosynthesis genes
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in early stages of differentiation. Lipin-1 knockdown alone
causes a 95% depletion of PAP1 activity. Despite the reduced
PAP1 activity and alterations in early adipogenesis, lipin-
silenced cells differentiate and accumulate neutral lipids.
Even combinatorial knockdown of lipins shows mild effects
on triacylglycerol accumulation in mature adipocytes.
Conclusions/interpretation Overall, our data support the
hypothesis of alternative pathways for triacylglycerol
synthesis in human adipocytes under conditions of repressed
lipin expression. We propose that induction of alternative lipid
phosphate phosphatases, along with the inhibition of lipid
hydrolysis, contributes to the maintenance of triacylglycerol
content to near normal levels.




DNL De novo lipogenesis
ER Endoplasmic reticulum
FAO Fatty acid oxidation
LPP Lipid phosphate phosphatases
ORO Oil Red O staining
PAP Phosphatidate phosphatase
PPAR Peroxisome proliferator activated receptor
SGBS Simpson–Golabi–Behmel syndrome
siRNA Small interfering RNA
SAT Subcutaneous adipose tissue
TAG Triacylglycerol
VAT Visceral adipose tissue
Introduction
Triacylglycerols (TAGs) are neutral lipids that act as the major
energy storage molecules, repository for fatty acids, and
phospholipid precursors [1]. Adipocytes are the specialised
cells for neutral lipid storage and one of their important
physiological functions is to buffer the toxicity caused by
NEFAs. Excessive calorie intake or genetic disorders can lead
to lipid deposition in ectopic tissues, impair their function and
lead to dyslipidaemia, insulin resistance and type 2 diabetes
[2, 3].
Lipins are Mg2+-dependent phosphatidate phosphatases
(PAP1) with a central role in lipid metabolism, and catalyse
the dephosphorylation of phosphatidate to diacylglycerol
(DAG), which can be (1) acylated to form TAG, or (2) used
in phospholipids synthesis [4, 5]. A second type of PAP
activity is mediated by Mg2+-independent transmembrane
lipid phosphate phosphatases (LPPs, also known as PAP2),
which are thought to regulate signalling properties of
phosphatidate and DAG [6].
Fungi, nematodes and insects express one lipin, whereas
mammals express three paralogues called lipin-1, -2 and -3
that exhibit distinct but overlapping expression in many
mouse and human tissues [5]. Consistent with their key
metabolic role, loss of lipin function disrupts TAG production,
membrane organisation and phospholipid synthesis in several
model organisms [7]. Interestingly, besides their enzymatic
functions, lipins also regulate transcription [8–13]. For
instance, lipin-1 transcriptional co-regulation of the
peroxisome proliferator activated receptor (PPAR)A/PPAR
coactivator 1α axis modulates fatty acid oxidation (FAO) in
liver [9].
Lpin1 gene was originally identified as the deficient gene
causing lipodystrophy, insulin resistance, peripheral
neuropathy and neonatal fatty liver in the fld (also known as
Lpin1) mouse model [14]. Loss of lipin-1 in mice blocks
adipogenesis at an early stage preceding TAG accumulation,
suggesting a distinct role of lipin-1 in differentiation [15, 16].
Consistently, small interfering RNA (siRNA)-mediated
silencing of lipin-1 in mouse 3T3-L1 cells potently inhibits
adipogenesis [10, 17]. In contrast, deleterious mutations
in the LPIN1 gene in humans, which lead to recurrent
rhabdomyolysis in childhood, do not compromise adipose
tissue [18]. The basis of this difference between mice and
humans is unknown; it has been hypothesised that it is due
to compensation by the other two lipins [18]. Nevertheless,
genetic variation in LPIN1 and LPIN2, and reduced LPIN1
expression levels and PAP1 activity in human adipose tissue
have been associated with type 2 diabetes [19–25], which
suggests a loss of their protective role against lipotoxicity.
While most of the studies have been performed on mice,
very little is known on the roles of lipin-1 in human adipocyte
physiology, while there is virtually no information on lipin-2
and -3. This prompted us to investigate the functions of the
three lipins in type 2 diabetes and in human adipocytes by
studying the effects of loss-of-function.
Methods
Reagents Unless otherwise stated, all reagents were supplied
by Sigma-Aldrich Corporation (St. Louis, MO, USA). Human
insulin was purchased from NovoNordisk (Bagsværd,
Denmark); rosiglitazone from Cayman Chemical (Ann
Arbor, MI, USA); and cell culture media from Gibco
(Thermo Fisher Scientific, Waltham, MA, USA).
Human adipose tissue biopsy collection The cross-sectional
study has been previously described [26, 27]. We used a
cohort of 71 participants for the gene expression analysis,
and of 28 males for protein analysis. They were grouped as:
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(1) normoweight (BMI between 18.50 and 24.99), (2) obesity
(BMI ≥25) and (3) obesity with type 2 diabetes (hereafter
type 2 diabetes). Group characteristics are described in elec-
tronic supplementary material (ESM) Table 1A and 1B, re-
spectively. Samples were obtained at the Joan XXIII
University Hospital (Tarragona, Spain). VATand SATsamples
(gene expression) and SAT samples (protein expression) were
obtained during abdominal elective surgical procedures
for benign pathologies (cholecystectomy or surgery for
abdominal hernia). The Ethics Committee approved the study
and informed consent was obtained from all participants.
Participants had no systemic disease other than obesity [28]
or type 2 diabetes [29]. See ESM Methods for further details.
Cell culture and differentiation Simpson–Golabi–Behmel
syndrome (SGBS) cells, a well-established system for studies
of human adipocyte biology [30, 31], were differentiated as
described [30], except that 1 nmol/l of insulin, 0.1 μmol/l
cortisol, 2 μmol/l rosiglitazone and 25 nmol/l dexamethasone
were used. See ESM Methods for detailed information.
Adipose-derived stem cells were isolated from adipose
tissue (n = 3 female donors; age (years) 37.4 ± 6.4, BMI
(kg/m2) 25.9 ± 3.0) from patients undergoing elective
liposuction surgery. See ESM Methods for the isolation,
proliferation and adipogenic procedure details.
Quantification of expression levels Protein content in cell
lysates (lysis buffer: 50 mmol/l HEPES pH 7.4, 150 mmol/l
NaCl, 4 mmol/l MgCl2, 1% Triton X-100 and protease
inhibitors) was quantified by using the bicinchoninic acid
assay (Pierce, Rockford, IL, USA). See ESM for western blot
procedures. Antibodies against lipin family members were
previously described [17, 32]. Quantitative PCR was
performed as previously described [27], and expressed
relative to cyclophilin A and to control. See ESM for detailed
information and ESM Table 2A and 2B for commercial
reagents.
Cell Fractionation For cell fractionation, SGBS cells were
grown and differentiated until day 10. Subcellular fractions
were obtained by using hypotonic lysis followed by high salt
extraction of nuclei. See ESM Methods for further details.
Gene silencing Transfections of SGBS cells with siRNA
oligonucleotides were carried out by using Lipofectamine
RNAiMAX transfection reagent (Thermo Fisher Scientific).
Pre-adipocyte knockdowns were performed as a two-shots
transfection of a mix of two siRNA duplexes per gene
(12.5 nmol/l of each duplex) (see ESM Table 2C): reverse
transfection at the start of the experiment and forward
transfection the day before confluence. The non-targeting
control concentration depended on total siRNA amount of
the single and multiple knockdowns.
Neutral lipid accumulation and metabolism Data were
obtained from differentiated SGBS cells and normalised by
protein content. For TAG analysis, cells were processed as
previously described [32], except that the supernatant fraction
was analysed with the Serum Triglyceride Determination kit
(Sigma). Glycerol release to cell culture media was quantified
by using the Free Glycerol Determination Kit (Sigma). Fatty
acid and glucose incorporation into TAGs, and FAO analysis
were performed as previously described [33], with slight
modifications (see ESM Methods for details).
Enzyme assay Cell lysates (lysis buffer: 50 mmol/l Tris-HCl
pH 7.5, 0.25 mol/l sucrose, 10 mmol/l 2-mercaptoethanol,
protease inhibitors) were subjected to centrifugation at 1000
g for 10 min at 4°C to remove cell debris. Protein
concentration was determined by the method of Bradford
[34] using BSA as a reference protein. Preparation of the
substrate and measure of PAP activity was as previously
described [35–37]. See ESM Methods for details. The
Mg2+-independent LPP activity was measured in the same
reaction mixture except that 2 mmol/l EDTAwas substituted
for 0.5 mmol/l MgCl2. The Mg
2+-dependent PAP1 activity
was determined by subtraction of LPPs activity from PAP
activity. A unit of PAP activity (expressed as units/mg protein)
was defined as the amount of enzyme catalysing the formation
of 1 nmol of product/min.
Metabolomic analysis SGBS cells were grown, transfected
with siRNA as explained above, and differentiated to day 4. In
brief, lipids were extracted from lyophilised samples by using
dichloromethane/methanol and water. The organic phase
(lipidic) was collected, dried under a stream of nitrogen, and
resuspended in acetonitrile/isopropanol/water for untargeted
LC-MS analysis. Differentially regulated lipids (p value
<0.05 and fold >2) were retained for compound identification
byMS/MS analyses. See ESMMethods for detailed procedures.
Statistical analysis Statistical analysis was performed by
using the SPSS software version 15 (Chicago, IL, USA).
ANOVA, Kruskal–Wallis, Pearson χ2, Spearman correlation
and Linear Stepwise Regression tests were performed for the
human cohort analysis, and theGeneral LinearModel Univariate
test for in vitro experiments. Statistical power in the cohort
analysis was ≥80%. The level of significance was set atα=0.05.
Results
Adipose tissue expression levels of the lipin family is
altered in type 2 diabetes To investigate the roles of lipin
paralogues in adipose tissue, we started by examining their
gene expression in paired abdominal subcutaneous (SAT)
and visceral (VAT) adipose tissue biopsies. As shown in
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Fig. 1a–c and ESM Fig. 1a–c, LPIN1 expression was reduced
in both SAT (p<0.001) and VAT (p=0.021) in the obesity and
type 2 diabetes groups compared with normoweight. LPIN2
expression was similar among groups. In contrast, SAT LPIN3
expression was significantly increased in the type 2 diabetes
(p=0.018). At the protein level, SAT showed only lipin-1 was
downregulated in obesity and in type 2 diabetes compared
with normoweight (p=0.034) (Fig. 1d–f).
Correlation analysis showed a negative association of
LPIN1 expression levels with BMI, HOMA-IR and plasma
TAG levels. In contrast, expression of LPIN3 positively
correlates with fasting glucose (SAT) and NEFA (VAT)
(Table 1). Regression analysis was performed, assessing age
and sex as confusing and interacting variables, and showed
that (1) SAT LPIN1 expression depends negatively on
HOMA-IR (R=0.466, p=0.005, excluded variables: BMI,
TAG, age and sex; LPIN1SAT=0.37× log10HOMA+0.984),
and (2) SAT LPIN3 expression depends positively on plasma
glucose levels (R=0.414, p=0.002, excluded variables: age
and sex; LPIN3SAT ¼ 1 10 1:202log10Glucose−0:961½ ).
The observed changes of the lipin family expression in type
2 diabetes participants may account for the altered PAP1
activity in adipocytes from these patients. Moreover, LPIN3
expression is associated with fasting glucose levels.
Alterations in lipin-3 protein levels in SATof participants with
type 2 diabetes may be masked by its presence also in the
stromal vascular fraction (data not shown).
The three lipin familymembers have a role in early human
adipogenesis Next, we examined the expression of lipins
during adipogenesis. Lipin-1 was induced, and lipin-2 and
lipin-3 levels were present along SGBS adipogenesis with
slight variation (Fig. 2a, b). Thus, SGBS adipocytes, similar
to differentiated adipose-derived stem cells (ESM Fig. 1d),
express the three lipin paralogues. Finally, under baseline
conditions, the three lipins partitioned between the cytosolic,
intranuclear and membrane-bound forms in SGBS adipocytes
(ESM Fig. 1e).
To address the effects of decreased PAP1 activity on
adipogenesis, we depleted each lipin member prior to the
induction of adipogenesis in SGBS pre-adipocytes (by using
siRNA; see Methods and Fig. 2c). Cells were analysed at day
4 after differentiation to assess adipogenic early events.
Protein expression analysis was used to confirm knockdowns
and evaluate possible compensatory mechanisms among
lipins. Lipin-1 depleted cells responded by compensatory
upregulation of lipin-2 protein (Fig. 2d and ESM Fig. 1f),
but not LPIN2 transcript levels (data not shown).
Conversely, single lipin-2 and lipin-3 knockdowns led to


























































































































































































































Fig. 1 Altered expression of the lipin family in type 2 diabetes adipose
tissue. Participants were grouped by BMI and type 2 diabetes (T2D).
(a–c) mRNA expression relative to cyclophilin A and to a calibrator that
consisted of a mix of mRNA samples (n=17, 43 and 11 samples for the
normoweight [NW], obesity andT2Dgroups, respectively), and (d–f) protein
expression normalised to actin (n=9, 10 and 9) were quantified in human
abdominal subcutaneous adipose tissue. Data represent mean ± SD;
*p<0.05, ***p<0.001 vs normoweight; ANOVA and Kruskal–Wallis tests
Table 1 Correlation analysis in
abdominal SAT and VAT adipose
tissue biopsies from 71
participants
Variable SAT VAT
LPIN1 LPIN2 LPIN3 LPIN1 LPIN2 LPIN3
BMI −0.349** −0.021 0.220 −0.283† −0.091 0.034
HOMA-IR −0.471** −0.104 −0.006 −0.329* −0.139 −0.006
Glucose −0.349** 0.253† 0.357** −0.119 0.189 0.298†
Insulin −0.522*** −0.169 −0.039 −0.340** −0.179 0.017
Triacylglycerol −0.319** −0.018 0.072 −0.202 0.131 0.238
NEFA −0.095 0.129 0.128 −0.029 0.125 0.336**
Glycerol −0.188 −0.105 0.144 −0.113 0.097 0.274†
Spearman coefficient of the correlation analysis is shown. *p< 0.05, **p< 0.01, ***p < 0.001
Where statistical power is lower than 80%: † p < 0.05
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Analysis of PAP1 activity showed that lipin-1 accounted for
almost all PAP1 activity (lipin-1-depleted cells showed 5% of
PAP1 activity in the control), with lipin-2 and lipin-3 single
knockdowns reducing it to 49% and 61%, respectively
(Fig. 2e).
Next, we analysed incorporation of fatty acids and glucose
into TAGs. While esterification of fatty acids was
downregulated in lipin-1- and lipin-2-depleted cells, glucose
incorporation into TAGs decreased in all three lipin-depleted
cells (Fig. 2f).
Finally, we analysed the expression levels of transcription
factors that promote early adipogenesis. CEBPA was
downregulated in cells depleted of any lipin family member,
and CEBPB was decreased upon lipin-2 deficiency (Fig. 2g).
Under these conditions, gene expression of two key
transcription factors regulated by CCAAT/enhancer binding
proteins, PPARG and SREBP1 were downregulated
(Fig. 2g), and also at the protein level (ESM Fig. 2a, b).
CEBPD showed a significant upregulation in cells depleted
of any lipin family member (Fig. 2g), probably due to the
triggering of a compensation mechanism.
Given the role of lipins in neutral lipid biosynthesis, we
next explored expression of lipogenic genes. The expression
of these genes was significantly downregulated in cells
depleted of any lipin family member (Fig. 2h). In contrast,
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Fig. 2 Single knockdowns of
lipins in SGBS pre-adipocytes.
SGBS pre-adipocytes were
induced to differentiate, and
mRNA (a) and protein (b) levels
were analysed during
adipogenesis at the given time
points (n= 3). Data represent
mean ± SD of fold induction over
day 0. (c) Knockdowns of single
lipin members were performed in
pre-adipocytes, adipogenesis was
induced (day 0) and cells were
collected at day 4. (d) Lipin
protein levels (n= 7), (e) PAP1
activity (control: 23.10
± 5.12 nmol min−1 mg−1) (n= 3),
(f) fatty acid (FA) and glucose
incorporation into TAGs (control,
fatty acids: 220.8
± 185.7 arbitrary units TAG/μg
protein, glucose: 3.47
± 6.30 arbitrary units TAG/μg
protein) (n = 3), andmRNA levels
of (g) early adipogenic
transcription factors (n = 3), and
(h) lipogenic genes (n= 3) were
analysed. Gene expression is
expressed relative to cyclophilin
A and to non-targeting control.
Protein expression is normalised
to actin levels. Data represent
mean ± SD of fold increase over
non-targeting controls (set as 1).
*p< 0.05, **p< 0.01,
***p< 0.001, General Lineal
Model Univariate test. (a, b)
White squares, LPIN1; grey
squares, LPIN2; black squares,
LPIN3; (d–h) white bars, LPIN1
knockdown; grey bars, LPIN2
knockdown; black bars, LPIN3
knockdown
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upregulated in the lipin-1 and lipin-2 knockdowns (Fig. 2h).
Lipid quantification by mass spectrometry showed that,
among the lipid species that were altered, the levels of most
DAG (ESM Fig. 2c) and TAG (ESM Fig. 2d) species were
downregulated in cells depleted of any lipin compared with
controls. Interestingly, phosphatidate levels did not change
(data not shown).
Overall, despite the crosstalk between lipin family
members, lipin-1 silencing leads to a 95% depletion of PAP1
activity. However, our results point to a role of all three
members on early stages of human adipogenesis.
Single lipin silencing does not block TAG accumulation
in fully differentiated adipocytes Next, we analysed the
effects of lipin silencing in SGBS pre-adipocytes on late
adipogenesis. Similarly to the above experiments, we depleted
each lipin member prior to induction of adipogenesis in SGBS
pre-adipocytes, and cells were analysed at day 10 after
differentiation (Fig. 3a), where protein downregulation of
lipins still persisted (Fig. 3b and ESM Fig. 3a).
At day 10, lipin-1 depleted cells still responded by
compensatory upregulation of lipin-2 protein (Fig. 3b and
ESM Fig. 3a). Additionally, both single lipin-2 and lipin-3
knockdowns led to lower protein levels of the other lipins.
PAP1 activity analysis showed that lipin-1 accounted for
almost all PAP1 activity (lipin-1-depleted cells showed 3%
of the activity in the control). Lipin-2 and lipin-3 single
knockdowns reduced PAP1 activity only slightly (84% and
74%, respectively) (Fig. 3c).
Next, we assessed neutral lipid accumulation. Depletion of
any lipin triggered a slight reduction (15% to 34%) in TAG
accumulation (Fig. 3d). Expression of key transcription
factors for lipogenesis (ESM Fig. 3a, b) and genes of lipid
biosynthesis (ESM Fig. 3c) were altered to a lesser extent
compared with the effects observed at day 4.
Finally, fatty acid esterification into TAGs and
α-glycerophosphate synthesis/de novo lipogenesis (DNL)
were downregulated in cells depleted of any lipin (Fig. 3e).
Compared with day 4, lipin-3 depletion also showed reduced
fatty acid esterification into TAGs at day 10.
Overall, the effects of lipin knockdown were mild on fully
differentiated adipocytes suggesting that cells overcame the
initial impairment of lipid gene expression. This may be due
to the existence of enough remnant protein amounts of lipins,
although PAP1 activity at day 10 was still almost absent in the
lipin-1 knockdowns.
Combinatorial silencing of lipins does not further alter the
phenotype of fully differentiated adipocytesWe then asked
whether compensation by other lipin family members might
help cells to recover the initial alterations shown at day 4 after
adipogenesis. We used a combinatorial knockdown to deplete
combinations of two of the three lipins in SGBS pre-
adipocytes (see Methods), and analysed cells at day 10 of
differentiation (as in Fig. 3a).
Double lipin-1 and lipin-3 knockdowns led to an
upregulation of lipin-2 protein levels (Fig. 4a and ESM
Fig. 4). This compensatory pattern hindered the efficiency of
lipin-2 knockdown in the double (lipin-1 and -2) and triple
knockdown cells. Nevertheless, PAP1 activity in the triple
knockdown was residual compared with the control
(0.18±0.31 vs 39.29±3.42 nmol min−1 mg−1).
Despite the almost complete lack of PAP1 activity,
neutral lipid accumulation was not totally compromised in
the triple knockdown (Fig. 4b). This is in agreement with
the fact that deleterious mutations in LPIN1 do not affect
adipose tissue development in humans, and it suggests that
it is unlikely to be due to a compensatory upregulation
of lipin-2 (Fig. 2d), since the double lipin-1 and -2
knockdown shows a similar reduction in the content of
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Fig. 3 Lipin-depleted SGBS pre-adipocytes can differentiate into
adipocytes. (a) Knockdowns of single lipin members were performed in
pre-adipocytes, adipogenesis was induced (day 0), and cells were collect-
ed at day 10. (b) Lipin protein levels (n= 3), (c) PAP1 activity (control:
38.88 ± 1.38 nmol min−1 mg−1) (n= 3), (d) total TAG content (control:
110.86 ± 37.29 mmol l−1 mg−1) (n = 3), and (e) fatty acid (FA) and
glucose incorporation into TAGs (control, fatty acids: 740.6 ± 292.3 arbi-
trary units TAG/μg protein, glucose: 3.73 ± 2.60 arbitrary units TAG/μg
protein) (n= 3) were analysed. Data represent mean ± SD of fold increase
over non-targeting controls (set as 1); *p < 0.05, **p < 0.01,
***p< 0.001; General Lineal Model Univariate test. White bars, LPIN1
knockdown; grey bars, LPIN2 knockdown; black bars, LPIN3
knockdown
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Moreover, depletion of the three lipins did not significantly
affect fatty acid esterification into TAGs and only slightly
downregulated α-glycerophosphate synthesis/DNL (Fig. 4c),
pointing to an improvement compared with day 4 (day 4
incorporation of fatty acids: 0.52 ± 0.35, p=0.006, and of
glucose: 0.32±0.15, p<0.001, fold over the control level).
Consumption of TAGs is reduced in lipin-depleted SGBS
adipocytes Lipid droplets accumulate neutral lipids in a
dynamic manner, with a balance among lipid biosynthesis,
lipid hydrolysis and FAO in mitochondria. To test whether
cells protect intracellular lipids by reducing its consumption,
we analysed the rates of palmitate oxidation. The results show
similar FAO rates in the control, single (Fig. 5a) and triple
knockdown (Fig. 5b). In contrast, levels of glycerol release
were downregulated compared with controls in the single
(Fig. 5c), and in all combinatorial knockdowns (Fig. 5d).
Thus, reduced consumption may contribute to the
accumulation of neutral lipids in lipin-depleted adipocytes.
The LPP family is upregulated under conditions of
repressed lipin expression Next, we tested whether the
Mg2+-independent LPPs could provide an alternative pathway
for DAG synthesis. LPP activity was highly induced in the
lipin-1 single knockdown (3.50 ± 1.18-fold increase over
control levels) (Fig. 6a), and in the triple knockdown
(2.74 ± 0.97-fold increase) at day 10 of differentiation
(Fig. 6b).
Moreover, the expression of LPP3 (also known as Plpp3/
PPAP2B) was upregulated in the single (Fig. 6c) and in the
combinatorial lipin knockdowns at day 10 (Fig. 6d) and,
similarly to lipogenic genes, upregulation was higher at day
four (ESM Fig. 5a). This was confirmed by using other
commercial sources of lipin-1 siRNA (ESM Fig. 5b) and
analysing LPP expression at day four of differentiation
(ESM Fig. 5c).
Propranolol, a nonspecific ß-blocker, is an effective PAP1
activity inhibitor and modestly effective as LPP inhibitor, with
the LPP3 isoform being more sensitive to inhibition [36].
Propranolol treatment during adipogenesis (Fig. 6e) altered
lipogenic gene expression (Fig. 6f) and blocked lipid droplet
formation in SGBS adipocytes (ESM Fig. 5d).
Discussion
Herein we have addressed the contribution of the lipin
paralogues to human adipogenesis. Decreased lipin
expression levels and PAP1 activity in adipose tissue have
been linked with insulin resistance [23–25]. In our cohort,
adipose tissue expression confirmed that lipin-1 is altered in
type 2 diabetes and that LPIN1 is negatively associated with
insulin resistance. Moreover, we show that LPIN3 transcript
levels are positively related with fasting glucose levels. This
prompted us to analyse separately the effects of gene silencing
of each lipin paralogue in adipogenesis.
Previous studies have established that lipin-1 plays a major
role in fat metabolism in rodents, with lipin-1 deficiency
causing lipodystrophy features in mice and rats [14, 38]. The
role of lipins in human adipogenesis is still undefined:
mutations in the LPIN1 gene have not yet been detected in
human lipodystrophy [39, 40]. Moreover, deleterious LPIN1
mutations cause paediatric rhabdomyolysis while fat
distribution, average weight and plasma biochemical variables
are normal [18]. Our data suggest that the lack of an essential


































































































*** *** *** 
Fig. 4 Combinatorial depletion of lipins in SGBS pre-adipocytes after full
differentiation. Multiple knockdowns of lipin members were performed in
pre-adipocytes, adipogenesis was induced (day 0) and cells were collected
at day 10. (a) Lipin protein levels (n = 3–6), (b) total TAG content
(controls: 71.11 ± 36.40 and 101.79± 76.15 mmol l−1 mg−1 for double
and triple knockdowns, respectively) (n= 5), and (c) fatty acid (FA) and
glucose incorporation into TAGs in the triple knockdown (control, fatty
acids: 493.4 ± 226.4 arbitrary units TAG/μg protein, glucose: 3.51
± 2.26 arbitrary units TAG/μg protein) (n = 3) were analysed. Data
represent mean ± SD of fold increase over non-targeting controls
(set as 1); *p < 0.05, **p < 0.01, ***p < 0.001; General Lineal Model
Univariate test. White bars, LPIN1 and LPIN2 knockdown; light grey bars,
LPIN1 and LPIN3 knockdown; dark grey bars, LPIN2 and LPIN3 knock-
down; black bars, triple knockdown
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compensation by lipin-2 or lipin-3.We find that the triple lipin
silencing in SGBS pre-adipocytes maintains the ability to
incorporate fatty acids into TAG and accumulate neutral lipids
despite loss of nearly all PAP1 activity.
SGBS pre-adipocytes are differentiated in the absence of
serum and, therefore, neutral lipids should be obtained from
DNL. Besides, although glyceroneogenesis is the major
pathway for glycerol synthesis in the mature adipocyte
[41], during adipogenesis glycolysis may account for an
important source of α-glycerophosphate. Thus, glucose in-
corporation into TAGs may account for DNL, but also for
α-glycerophosphate synthesis via glyceroneogenesis and
glycolysis. Downregulated α-glycerophosphate synthesis/
DNL points to broader effects of lipin silencing other than
TAG synthesis. Moreover, the putative intranuclear roles of
lipin-1, -2 and -3 in SGBS adipocytes add some complex-
ity to the above.
The lipin family members cooperate for optimal PAP
activity in mouse adipose tissue [42], liver [43, 44], brain
[43] and human primary myoblasts [45]. Our data show that
human lipin-1 accounts for most PAP1 activity in SGBS
adipocytes and that upregulation of lipin-2 in lipin-1-
depleted cells does not compensate for PAP1 activity. By
contrast, downregulation of PAP1 activity in lipin-2 and
lipin-3 single knockdowns cannot be fully attributed to their














































































































































































Fig. 6 Induction of the LPP family under conditions of repressed lipin
expression. Knockdowns of single, double and triple lipin family
members were performed in pre-adipocytes, adipogenesis was induced
(day 0) and cells were collected at day 10. LPP activity in (a) the single
(control: 6.01 ± 0.60 nmol min−1 mg−1) (n = 3) and (b) triple knockdowns
(control: 4.82 ± 0.53 nmol min−1 mg−1) (n= 3), and expression levels of
the LPP family in (c) the single (n = 7) and (d) combinatorial knockdowns
(n = 4–7) were analysed. (e) SGBS pre-adipocytes were induced to
differentiate in presence of 100 μmol/l of propranolol (PrPol).
(f) mRNA levels of lipogenic genes were analysed (n= 3). Data represent
mean ± SD of fold increase over non-targeting controls (a–d) or
non-treated control (f); *p < 0.05, **p < 0.01, ***p < 0.001; General
Lineal Model Univariate test. (a, c) White bars, LPIN1 knockdown; grey
bars, LPIN2 knockdown; black bars, LPIN3 knockdown; (b, d) white bars,
LPIN1 and LPIN2 double knockdown; light grey bars, LPIN1 and LPIN3
double knockdown; dark grey bars, LPIN2 and LPIN3 double knockdown;























































































































Fig. 5 Consumption of neutral lipids in fully differentiated lipin-depleted
SGBS pre-adipocytes. Knockdown of single, double and triple lipin
family members was performed in pre-adipocytes, adipogenesis was
induced (day 0) and cells were collected at day 10. Palmitate oxidation
rates in (a) single (control: 0.77 ± 0.37 nmol h−1 mg−1) (n= 3), and (b)
triple knockdowns (control: 0.63 ± 0.28 nmol h−1 mg−1) (n= 3); glycerol
release in (c) single (control: 0.42 ± 0.12 mmol l−1 mg−1) (n= 3), and (d)
combinatorial knockdowns (controls, double: 0.36 ± 0.21, and triple:
0.21 ± 0.07 mmol l−1 mg−1) (n= 5) were analysed. Data represent mean
± SD of fold increase over non-targeting controls (set as 1); **p < 0.01,
***p< 0.001; General Lineal Model Univariate test. (a, c) White bars,
LPIN1 knockdown; grey bars, LPIN2 knockdown; black bars, LPIN3
knockdown; (b, d) white bars, LPIN1 and LPIN2 double knockdown;
light grey bars, LPIN1 and LPIN3 double knockdown; dark grey bars,
LPIN2 and LPIN3 double knockdown; black bars, triple knockdown
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Activation of non-lipin compensatory pathways may also
mask the lipin phenotypes. Nevertheless, (1) we found no
evidence, at the mRNA level, of upregulation of the
monoacylglycerol O-acyltransferase pathway that can
generate DAG from monoacylglycerol [46, 47] (data not
shown); and (2) cholesteryl esters levels are likely not
upregulated since the effect of lipin knockdown on neutral
lipid content looks similar by Oil Red O staining (ORO) and
TAG content (ORO: 0.76±0.06, and TAG: 0.85±0.13 in the
lipin-1 knockdown, and ORO: 0.74 ± 0.12, and TAG:
0.54±0.33 in the triple lipin knockdown, compared with the
control set as 1). In contrast, LPP activity was induced in the
lipin knockdowns, possibly due to an earlier upregulation of
their transcript levels (observed by day 4). Moreover,
inhibition of both lipins and LPPs with propranolol
completely blocked lipid droplet formation, although this fact
must be taken with caution because of the non-specificity of
this compound. LPPs hydrolyse phosphatidate as well as
different substrates, and act on the outer surface of plasma
membrane and in the luminal surface of endoplasmic
reticulum (ER) and Golgi membranes [6] and thus, it is not
clear if they can have access to the phosphatidate formed from
glycerol phosphate and acyl-CoA. However, in yeast, TAG
synthesised both in the cytosolic and luminal leaflets of the
ER membranes are efficiently packed into lipid droplets [48].
Another strategy to protect the lipid storage when
glycerolipid synthesis is compromised might be downregula-
tion of lipid hydrolysis and FAO. Lipin-1 regulates basal
lipolysis [49], and modulates FAO transcript expression levels
[9]. We show that all combinatorial knockdowns of lipins
downregulate basal lipolysis to a greater extent than reduction
of neutral lipid content.
In summary, we confirm that adipose tissue expression of
the lipin family is altered in type 2 diabetes. Furthermore, loss
of nearly all PAP1 activity, due to combined lipin-1, -2 and -3
knockdown, has only mild effects on final adipogenesis and
lipid accumulation in SGBS cells. Conversely, lipin-2 and
lipin-3 may contribute little to total PAP activity, but still play
a role in early adipogenesis. Our results suggest a compensa-
tion strategy to accumulate near normal neutral lipid levels,
activating other pathways (such as LPPs) and inhibiting TAG
hydrolysis. More work is clearly required to decipher whether
LPPs or other unknown pathways may compensate lack of
PAP1 activity.
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